Polar Capital Holdings PLC Exact Sciences Corp Transaction History

Polar Capital Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $119,219 - $179,064	-1,808 Reduced 19.57%	7,432 $507,000
Q2 2023 Dec 13, 2023	BUY	$62.68 - $95.05 $102,168 - $154,931	1,630 Added 21.42%	9,240 $867,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $102,168 - $154,931	1,630 Added 21.42%	9,240 $867,000
Q1 2023 Dec 13, 2023	BUY	$47.19 - $70.77 $8,399 - $12,597	178 Added 2.4%	7,610 $516,000
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $154,547 - $231,771	3,275 Added 75.55%	7,610 $516,000
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $131,567 - $230,405	4,335 New	4,335 $214,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.